Aroa Biosurgery hopes for sales boost after study finds high healing rates

Aroa Biosurgery hopes for sales boost after study finds high healing rates
Aroa founder Brian Ward says the largest study to date of its tissue repair products bodes well for the firm. (Image: Aroa Biosurgery)
Rebecca Stevenson
Aroa Biosurgery founder Brian Ward says a new large study proving the efficacy and cost saving of its tissue repair products should help to convince conservative surgeons to use them. In late December Australian Securities Exchange (ASX) listed Aroa announced a peer-reviewed study of 120 inpatients for two of its treatments, Myriad Matrix and Myriad Morcells, in lower limb reconstructions. The study, which was published in a plastic and reconstructive surgery journal in December, found one application of Myriad achieved tissue coverag...

More Markets

NZ sharemarket closes lower, tech stocks buoyed by Oracle update
Markets Market Close

NZ sharemarket closes lower, tech stocks buoyed by Oracle update

The S&P/NZX 50 Index closed down 0.35% or 47.09 points.

Tom Raynel 11 Sep 2025
How RFK Jnr's Medicare reform could aid this NZ firm
Markets

How RFK Jnr's Medicare reform could aid this NZ firm

'Wild west' conditions hampered its US push. They could be changing.

Average home insurance tops $2,000
Infrastructure Risky Business

Average home insurance tops $2,000

Insurance premiums in New Zealand have increased dramatically in recent years.

Michael Neilson 11 Sep 2025